Diagnostic potential of western blot analysis of sera from dogs with Leishmaniasis in endemic areas and significance of the pattern. by Aisa Nache, Maria Jesús et al.
154
Am. J. Trop. Med. Hyg., 58(2), 1998, pp. 154–159
Copyright q 1998 by The American Society of Tropical Medicine and Hygiene
DIAGNOSTIC POTENTIAL OF WESTERN BLOT ANALYSIS OF SERA FROM DOGS
WITH LEISHMANIASIS IN ENDEMIC AREAS AND SIGNIFICANCE OF THE PATTERN
M. JESUS AISA, SOLEDAD CASTILLEJO, MONTSERRAT GALLEGO, ROSER FISA, M. CRISTINA RIERA,
MARIA DE COLMENARES, SARA TORRAS, XAVIER ROURA, JOAN SENTIS AND MONTSERRAT PORTUS
Laboratori de Parasitologia, Departament de Microbiologia i Parasitologia Sanitaries, i Unitat de Bioestadistica,
Departament de Salut Publica, Universitat de Barcelona, Barcelona, Spain; Hospital Clinic de Veterinaria,
Facultat de Veterinaria, Universitat Autonoma de Barcelona, Barcelona, Spain
Abstract. Serum samples collected from 237 dogs in Catalonia (northeastern Spain) were screened by Western
blot analysis to detect the presence of antibodies specific to different Leishmania infantum polypeptide fractions.
Leishmaniasis was confirmed in 72 of these dogs by direct examination and/or culture. Another 165 animals from
the Priorat region were studied periodically for 2–8 years between 1987 and 1995, giving a total of 565 determinations.
A control group of 93 dogs from nonendemic areas was also studied. Sera from dogs with leishmaniasis recognized
antigens with molecular weights ranging from 12 to 85 kD. The most sensitive antigens were those of 70, 65, 46,
30, 28, 14, and 12 kD, which were recognized by 75%, 75%, 78%, 75%, 81%, 79%, and 75%, respectively, of the
sera from dogs with positive parasitologic examination results. Antigens of 70 and 65 kD were also recognized by
two dogs from nonendemic areas. Antigens of 14 and 12 kD were the first to be recognized by sera of asymptomatic
dogs with titers less than the cut-off value of the dot-ELISA that increased during the longitudinal study, and the
presence of antibodies specific for these fractions was observed for up to six years before seroconversion observed
by dot-ELISA. These antibodies were also the first to disappear in dogs in which the disease was self-limited. The
study corroborates the high sensitivity and specificity of Western blots in the diagnosis of canine leishmaniasis when
the bands of low molecular weight (less than 46 kD) are considered, and indicates that fractions of 14 and 12 kD
are useful in detecting early forms of the disease.
Canine leishmaniasis is endemic in Spain, where approx-
imately 5% of the dog population are infected. Diagnosis of
the disease relies on direct examination and culture of lymph
nodes or bone marrow aspirates and serologic techniques.
Interpretation of results obtained by serologic techniques
(ELISA, dot-ELISA, immunofluorescence assay [IFA]) when
dogs from endemic areas are examined is often difficult. Al-
though these techniques can detect active leishmaniasis when
a high level of specific antibodies is present, they do not dis-
tinguish between the various phases of the disease when lev-
els of antibodies are at or near the cut-off level. Different
seroepidemiologic studies performed in the Mediterranean
area1–4 indicate that the proportion of sera with low antibody
titers is directly related to the level of endemicity. The study
of the natural evolution of leishmaniasis in the Priorat focus
of northeastern Spain by a dot-ELISA technique showed that
40% of the dogs examined had low antibody titers.5 This low
level of antibodies may be a consequence of the latent period
of the disease, which can last from a few months to several
years, abortive or regressive forms of the disease, a low hu-
moral immunoresponse in the animal, or different host-para-
site contacts without the establishment of the parasite. Distin-
guishing between these situations is of great importance clin-
ically and epidemiologically.
Recent studies6–8 reported different results concerning the
pattern obtained in Western blot analysis of the specific hu-
moral immunoresponse to L. infantum antigens during the
active course of the disease and during therapy in human
leishmaniasis. Limited studies have been performed on
dogs,7, 9–12 and little is known about the natural evolution of
this immunoresponse during active or latent asymptomatic
canine infection, or during regression of the disease.
The aim of this study was to define the polypeptide frac-
tions of the Leishmania antigen that might be used in the
diagnosis of the disease, and to determine whether the pat-
tern obtained in Western blots could be used as a marker for
the evolution of disease.
MATERIALS AND METHODS
Sera. Sera were obtained from 237 dogs in Catalonia
(northeastern Spain), an area endemic for leishmaniasis, 72
of which had leishmaniasis as confirmed by direct exami-
nation and/or culture. Forty-one were treated at the Veteri-
nary Hospital of the Facultat de Veterinaria de Bellaterra in
Barcelona, and 31 were from a focus of leishmaniasis in
Priorat.
Sera from 165 animals from the natural focus in Priorat
(south of Catalonia) were periodically studied for 2–8 years
between 1987 and 1995, giving a total of 565 determina-
tions, with a mean of 3.4 determinations per dog (range 5
2–8). Clinical examination and blood collection were carried
out during the annual antirabies vaccination campaign. Com-
plete records of breed, sex, age, and size, were obtained for
epidemiologic purposes and clinical signs for leishmaniasis
were evaluated. Dogs were classified as asymptomatic when
there was no indication of Leishmania infection (moderately
enlarged lymph nodes found in a few cases were disregard-
ed); oligosymptomatic when moderate symptoms, including
two signs of infection (enlarged lymph nodes and onycho-
gryposis or furfuraceous dermatitis/depilation) were ob-
served; and symptomatic when evident symptoms including
three or more signs of disease were observed.
Animals were examined at annual intervals. Many of the
animals died during the study without the cause of death
being established, and a large number of animals were also
lost during the study for a variety of reasons, such as
changes in residence and lack of permission of the owner to
continue the study. Parasitologic examination (direct exam-
ination and culture) could be performed only in some cases
due to difficulties in collecting repeated ganglionic aspirates
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TABLE 1
Recognition of the major Leishmania infantum antigens by sera of
72 dogs with leishmaniasis, sensitivity for each band in the di-
agnosis, its relationship with the presence of parasite (x2), and
intensity of this relation (C-Pearson’s coefficient of contingency)

































































































































under field conditions and from apparently healthy dogs. A
control group of 93 dogs from nonendemic areas (Switzer-
land, Sweden, and the Canary Islands) was also studied.
Blood samples were allowed to clot, and the serum was
separated by centrifugation and stored at 2408C until use.
Dot-ELISA. The technique was performed as previously
described.13 Briefly, the antigen used was whole promasti-
gotes of L. infantum fixed in 1.5% formaldehyde. Dots of 1
ml containing 105 cells were adsorbed onto a nitrocellulose
membrane in a bio-dot apparatus (Bio-Doty; Bio-Rad, Her-
cules, CA). Fifty microliters of serially diluted serum sam-
ples (from 1:100) in 20 mM Tris, 0.13 mM NaCl, pH 7.6,
containing 0.05% Tween 20 (TST) and 1% dry skim milk
was added to each well and incubated at 378C for 30 min.
After the dots were washed with TST, 50 ml of Protein A
labeled with horseradish peroxidase (Sigma, St. Louis, MO)
diluted 1:1,000 in TST was added and incubated at 378C for
30 min. After washing with TST, the entire membrane was
exposed to the chromogen reagent (4-chloro-1-naphthol
[Sigma]) and H2O2. Color development was visually deter-
mined and the cut-off value was established at a 1:800 di-
lution of serum.
Immunoblot analysis. Antigen for immunoblot was ob-
tained from promastigotes from culture in Schneider’s me-
dium (Sigma) containing 20% fetal calf serum at the expo-
nential growth phase. Cells were washed three times in phos-
phate-buffered saline, pH 7.4, counted, and adjusted to a
concentration of 3 3 108 promastigotes/ml in sample buffer
(0.5 M Tris-HCl, pH 6.8, 0.01 M EDTA, 5% sodium dodecyl
sulfate [SDS], 5% 2-mercaptoethanol, 0.0125% bromo-
phenol blue), and boiled for 5 min. Antigen was stored at
2408C until use.
Antigen electrophoresis on 0.1% SDS-15% polyacryl-
amide gels together with molecular mass proteins standards
(Standard Low Range; Bio-Rad) was performed on a Mini-
Gel AE 6400 Dual Mini Slab Kit (Atto, Bunkyo-ku, Japan).
Gels were run at 80 V for 2 hr at room temperature. Poly-
peptides were transblotted onto nitrocellulose sheets (0.45-
mm pore size, HAWP 304 FO; Millipore, Bedford, MA) and
the sheets were blocked with 20 mM Tris, 0.13 mM NaCl,
pH 7.6 (TS), 5% skim milk overnight at 48C. The sheets
were washed in TS and introduced into a multiscreen ap-
paratus (Mini Protean II, Multiscreen Apparatus; Bio-Rad).
Sera were diluted 1:200 in TS-1% skim milk, 0.2% Tween
20, and 500 ml of each sample was introduced into each
channel of the multiscreen apparatus and incubated for 2 hr
at 378C. Bound immunoglobulins were developed by incu-
bation with a 1:1,000 dilution of Protein A peroxidase con-
jugate (Sigma) for 1 hr. After the sheets were washed three
times with TST and a final time with TS, color was devel-
oped with 4-chloro-1-naphthol (Sigma) and H2O2 and the
reaction was stopped with tap water after 30 min.
Statistical analysis. The relationship between the differ-
ent antigen fractions recognized on Western blots and the
presence of the parasite in dogs was determined by the chi-
square test. The intensity of this relationship was calculated
with Pearson’s coefficient of contingency. Any P values ,
0.05 were considered statistically significant.
RESULTS
Seventy of 72 dogs with leishmaniasis had antibodies that
revealed 3–33 polypeptide fractions of the Leishmania an-
tigen with a molecular mass range between 12 and 85 kD.
The highest sensitivity was found for bands of 70, 65, 46,
30, 28, 14, and 12 kD (Table 1).
The specificity of the technique was calculated with the
sera of 93 dogs from nonendemic areas. Sera of four dogs
from Sweden reacted with some fractions of the Leishmania
antigen (75–70, 75–60, 65–60, 58, and 34 kD, respectively).
The coefficient of contingency for each band and the pres-
ence of the parasite was calculated (Table 1), and the strong-
est relationship was found for bands of 46, 30, 28, 14, and
12 kD. Based on these results, we considered the Western
blot to be positive when any one of the latter bands was
present and the sensitivity of the technique was calculated
to be 95.8%.
None of the animals negative by Western blot was positive
by dot-ELISA (. 1:400) and although a direct relationship
between the results obtained in the dot-ELISA and the West-
ern blot could not be established, in general, the number of
bands in the immunoblot increased with the titer obtained
by the dot-ELISA (Figure 1). The sensitivity obtained with
this technique for the same animals was 91.6%.
Epidemiologic study. One hundred sixty-five dogs from
the Priorat focus of leishmaniasis were studied serologically
(Western blot and dot-ELISA) for 2–8 years. With regards
to the serologic evolution of the animals, we observed the
following results. 1) Seventy-four of 165 dogs (group A)
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FIGURE 1. Comparison of the results obtained by dot-ELISA and Western blot (WB) in 72 dogs with leishmaniasis confirmed by direct
examination and/or culture.
FIGURE 2. Western blot analysis of sera from three positive dogs
(dot-ELISA, Western blot, and culture). Lanes a and b, dog no. 36;
a, 1991, dot-ELISA 1:1,600, asymptomatic; b, 1992, dot-ELISA 1:
1,600, asymptomatic. Lanes c and d, dog no. 31; c, 1991, dot-ELISA
1:6,400, asymptomatic; d, 1992, dot-ELISA 1:6,400, symptomatic.
Lanes e and f, dog no. 18; e, 1991, dot-ELISA 1:3,200, asympto-
matic; f, 1992, dot-ELISA 1:3,200, asymptomatic. All dogs died in
1993. Values on the right are in kilodaltons.
were negative throughout the study by Western blot (sera
did not reveal any antigen band of Leishmania) and negative
by dot-ELISA or less than the cut-off value. This group can
be considered as the cohort of negative animals and none of
them had symptoms of Leishmania infection. 2) Thirteen of
165 dogs (group B) remained Western blot positive through-
out the study. The symptoms of these dogs changed during
the study; eight were asymptomatic at the beginning of the
study but only three of them remained healthy at the last
examination (Figure 2). 3) Twenty-nine of 165 dogs (group
C) seroconverted. In these cases, the number of antigenic
fractions recognized increased gradually after the first ap-
pearance of bands of 12 and 14 kD (e.g., dogs 58, 140, and
145, Figure 3). Nineteen of 29 were asymptomatic at all
times, whereas 10 of 29 were oligosymptomatic at the last
examination. 4) Seven of 165 dogs (group D) showed a clear
reduction in the number of bands, together with a decrease
in the dot-ELISA titer. These animals were always asymp-
tomatic or oligosymptomatic; this was accompanied by a
reduction and/or disappearance of bands of low molecular
weights, (e.g., dogs 113 and 140, Figure 3). In two cases
there was an increase and a later reduction in the number of
bands in Western blots and in the titer of the dot-ELISA
(these animals are included in both groups C and D). We
believe that this corresponds to the self-healing population.
5) Serum observed from 38 of 165 dogs (group E) showed
at certain times proteins corresponding to bands not included
among those considered diagnostic (46, 30, 28, 14, and 12
kD). All of these dogs were negative by dot-ELISA or had
an antibody level less than the cut-off value (, 1:800), and
none became positive (either by dot-ELISA or Western blot)
during the period of the study (Figure 4). Twelve of the 38
dogs showed a single band of 70 kD. This single band was
also seen in the serum of one dog in group D (number 113,
Figure 3), which later became seronegative (by dot-ELISA
and Western blot) for three consecutive years. 6) Six of 165
dogs (group F) were observed that could not be included in
any of the above groups.
The relationship between results in the dot-ELISA and
Western blots for each sera and the clinical status of the
animals at the time of sampling is shown in Table 2. Most
sera with a negative dot-ELISA result (375) also had a neg-
ative Western blot result (365), and most sera with a positive
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FIGURE 3. Western blot analysis of serum of four dogs in which the titer in the dot-ELISA and the Western blot pattern changed over time.
Lanes a–c, dog no. 58; a, 1990, dot-ELISA 1:100; b, 1991, dot-ELISA 1:1,600; c, 1992, dot-ELISA 1:6,400; the dog remained asymptomatic.
Lanes d–h, dog no. 145; d, 1988, dot-ELISA 1:200; e, 1989, dot-ELISA 1:400; f, 1991, dot-ELISA 1:800; g, 1992, dot-ELISA 1:800; h, 1993,
dot-ELISA 1:800; the dog remained asymptomatic with the exception of 1992 when slight adenopatia and scattered depilations on the skin
were observed. Lanes i–n, dog no. 140; i, 1989, dot-ELISA negative; j, 1990, dot-ELISA 1:100; k, 1991, dot-ELISA 1:200; l, 1992, dot-
ELISA 1:800; m, 1993, dot-ELISA 1:100; n, 1994, dot-ELISA 1:100; cultures of lymph node aspirates and bone marrow were positive in
1992 and the dog remained asymptomatic in the control period. Lanes o–s, dog no. 113; o, 1991, dot-ELISA 1:400; p, 1992, dot-ELISA 1:
100; q, 1993, dot-ELISA negative; r, 1994, dot-ELISA negative; s, 1995, dot-ELISA negative; the dog remained asymptomatic with the
exception of the control in 1995, which had depilations on the ears. Values on the right are in kilodaltons.
FIGURE 4. Western blot analysis of two asymptomatic dogs with dot-ELISA titers that were negative or less than the cut-off value and did
not seroconvert. Lanes a–e, dog no. 94; a, 1989, dot-ELISA 1:100; b, 1991, dot-ELISA 1:200; c, 1992, dot-ELISA 1:100; d, 1993, dot-ELISA
negative; e, 1994, dot-ELISA 1:100. Lanes f–j, dog no. 59: years 1990, 1991, 1992, and 1994; dot-ELISA was negative in all controls. Values
are in kilodaltons.
dot-ELISA result (61) also had a positive Western blot result
(57). Only four sera positive by dot-ELISA had a negative
Western blot result. In all cases these dot-ELISA titers were
near the cut-off value (1:800) and Western blots revealed
bands other than those considered diagnostic. One of these
dogs became positive by Western blot and the dot-ELISA
titer increased to 1:3,200 in a second control; another dog
died the following year of undetermined causes and two re-
tained dot-ELISA titers less than the cut-off value and West-
ern blots with nonspecific bands for next two and three
years, respectively. Ten sera from eight asymptomatic dogs
with negative dot-ELISA results had positive Western blots;
five dogs were from group C and the bands were 14 or 12–
14 kD, and seroconversion by dot-ELISA was observed after
a variable period of time. For the remaining three dogs, no
additional data was available to evaluate the serology.
One-hundred twenty-nine sera with a dot-ELISA titer less
than the cut-off value corresponded to dogs included in all
the categories established above. In 58 sera, the Western blot
was negative and corresponded to dogs in group A. Another
37 sera were positive by Western blot and recognized a vari-
able pattern of antigenic fractions; 14 of them showed reac-
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TABLE 2
Comparison of the results obtained in the Western blot (WB) and
dot-ELISA in sera of asymptomatic, oligosymptomatic, and












Negative (n 5 375)
1:100–1:400 (n 5 129)



















* The dot-ELISA was considered positive when the titer was .1:400. The Western blot
was considered positive when any one of the fractions of 12, 14, 28, 30, and 46 kD of
Leishmania infantum antigen was revealed.
tivity only to the 14 or 12–14 kD bands in dogs in group C.
Low titers in the dot-ELISA and positivity by Western blot
were also observed in sera obtained from dogs in group D.
The remaining 34 sera with low dot-ELISA titers recognized
bands not considered diagnostic in dogs in group E, and
exceptionally, in group D.
Dogs with symptoms of Leishmania infections were al-
ways positive by Western blot and the pattern of antigenic
fractions recognized was not different from that recognized
by sera obtained during the asymptomatic phases of the dis-
ease when antibody levels were similar (Figure 2).
DISCUSSION
Immunoblot analysis has been recently found to be suit-
able for the diagnosis of visceral leishmaniasis in humans
and in dogs. However, some investigators disagree as to the
most specific and sensitive antigen bands recognized by sera
of patients and animals with leishmaniasis.6–12 Differences in
the antigens used, promastigotes from the exponential or sta-
tionary growth phase, different degrees of antigen reduction
as a consequence of different concentrations of SDS and 2-
mercaptoethanol in the sample buffer, and separation of the
soluble fractions of the antigen and the pellet are some of
the factors that could influence the results. Moreover, the
size of the slab gels and the concentration of polyacrylamide
used, as well as different molecular weight markers, may
introduce slight variations in the separation of the fractions
and in the relative molecular weights calculated.
The results obtained here are consistent with those ob-
tained by Mary and others6 in patients with visceral leish-
maniasis in which antigens of 14, 16, 28, 30, 46, and 68 kD
were recognized by 92%, 95%, 63%, 80%, 69%, and 89%
of the patients’ sera, and those of Mancianti and others11 in
dogs, who found that all positive sera, even when the IFA
titer was relatively low, recognized antigens of 30 and 73
kD. Other antigens frequently recognized were those with
molecular weights of 16, 18, 26, 33, 50, and 117 kD.11 There
may be identity between the 12-, 14-, 28-, 30-, 46-, and 70-
kD antigens in the present study and the 14-, 16-, 28-, 30-,
46-, and 68-kD antigens reported by Mary and others6 and
the 16-, 18-, 30-, 33-, 50-, and 73-kD antigens of Mancianti
and others.11 In a recent study, proteins of 14 and 16 kD
have been identified as nuclear proteins and designated p14
and p18.14
The calculation of the sensitivity of the test in this study
was performed on dogs with positive parasitologic exami-
nation results and with symptoms compatible with leishman-
iasis. This combination of clinical signs and positive para-
sitologic examination results usually arises in advanced ac-
tive diseases. This is why in most of these dogs, the dot-
ELISA results were positive and the Western blots revealed
a large number of bands (Figure 1). The epidemiologic study
was performed on the canine population of the Priorat area
that participated in an antirabies vaccination campaign and
were not necessarily ill. In this case, many dogs were in the
early subclinical phases of the disease. In rural areas of Cat-
alonia such as the area studied, few dogs are specifically
treated for leishmaniasis and many are killed when they are
in the advanced phases of the disease. The study of serum
in early phases, using techniques that do not distinguish be-
tween antigenic fractions (IFA, ELISA, dot-ELISA, direct
agglutination test) often results in low titers that cannot de-
fine disease or a healthy condition.
Based on the results of this study, it appears that the West-
ern blot is able to discriminate early phases of the disease
in animals that are negative or have low antibody titers with
the techniques mentioned above. The presence of antibodies
specific to the 12- and 14-kD fractions in asymptomatic dogs
may last for a variable period of time and positivity by dot-
ELISA and/or clinical disease has been observed up to six
years after detecting the presence of these specific antibod-
ies. This is in agreement with previous observations that
when healthy dogs seroconverted, the first bands to appear
on Western blots were those of 14 and 16 kD.6 Moreover,
the long period during which such bands may be found in
asymptomatic dogs before they reach the cut-off level of the
dot-ELISA could explain previous findings that fractions of
low molecular weight were recognized by human controls
in endemic areas in France6 and Spain,8 but not by humans
from nonendemic regions.
Dogs that showed a regression of the disease and of an-
tibody titers (group D) had a reduced activity to certain an-
tigen bands: those to the 12- and 14-kD bands disappeared
or were reduced in intensity while others to higher molecular
weight bands remained. This suggests that in some cases the
presence of specific antibodies to antigens of high molecular
weight (. 46 kD) could be related to previous contact with
the parasite. Nevertheless, the significance of some bands of
high molecular weights, in particular those of 60, 65, 70,
and 75 kD, which often appear associated, is not clear be-
cause they were sporadically recognized by sera of dogs
from nonendemic areas. These bands were also recognized
by a high proportion of human negative control sera in Cat-
alonia8 and southern France,6 which are areas endemic for
leishmaniasis. Proteins of 70- and 72-kD in Leishmania an-
tigens have been identified as members of the highly con-
served heat-shock protein 70 (hsp70) family, and they are
recognized not only by most human visceral leishmaniasis
sera but also by sera from patients with other infectious dis-
eases, such as tuberculosis, toxoplasmosis, and hydatidosis.15
The response in dogs to hsp70 during leishmaniasis is spe-
cifically elicited by the parasite protein and is not an auto-
immune reaction.16 Nevertheless, the similarity between
hsp70 from different infectious agents could explain the
presence of cross-reactive antibodies.
This study corroborates the high sensitivity (95.8%) and
specificity (100%) of Western blots for the diagnosis of ca-
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nine leishmaniasis when antigen bands with molecular
weights of 12, 14, 28, 30, and 46 kD are considered. The
main advantage of Western blots over other serologic tech-
niques that use whole Leishmania antigen is in its capacity
to discriminate early asymptomatic infections. Identification
of the 12- and 14-kD antigen fractions of Leishmania in dogs
can be used to detect early phases of this disease, which can
last many years, and possibly to evaluate the resolution of
the disease.
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